Monobenzone [INN] en es it fr

Monobenzone [INN] Brand names, Monobenzone [INN] Analogs

Monobenzone [INN] Brand Names Mixture

  • No information avaliable

Monobenzone [INN] Chemical_Formula


Monobenzone [INN] RX_link

Monobenzone [INN] fda sheet

Monobenzone [INN] msds (material safety sheet)

Monobenzone_[INN] MSDS

Monobenzone [INN] Synthesis Reference

No information avaliable

Monobenzone [INN] Molecular Weight

414.476 g/mol

Monobenzone [INN] Melting Point

No information avaliable

Monobenzone [INN] H2O Solubility


Monobenzone [INN] State


Monobenzone [INN] LogP


Monobenzone [INN] Dosage Forms

Powder for solution

Monobenzone [INN] Indication

For the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drugs.

Monobenzone [INN] Pharmacology

Nafcillin is a semisynthetic antibiotic substance derived from 6-amino-penicillanic acid. The drugs in this class are highly resistant to inactivation by staphylococcal penicillinase and are active against penicillinase-producing and non penicillinase-producing strains of Staphylococcus aureus. The penicillinase- resistant penicillins are active in vitro against a variety of other bacteria.

Monobenzone [INN] Absorption

No information avaliable

Monobenzone [INN] side effects and Toxicity

Serious toxicity is unlikely following large doses of nafcillin. Acute ingestion of large doses of nafcillin may cause nausea, vomiting, diarrhea and abdominal pain. Acute oliguric renal failure and hematuria may occur following large doses.

Monobenzone [INN] Patient Information

Monobenzone [INN] Organisms Affected

Enteric bacteria and other eubacteria